Showing results (1551-1560 of 1,583) with videos related to

Sort By:
Pageof 159
Annals of the Rheumatic Diseases|December 25, 2012
Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registryJacques-Eric Gottenberg, Gael Cinquetti, Claire Larroche, et al.
Cell|March 7, 2026
Deltaviruses spread through a viral Trojan HorseJoe McKellar, Aurélien Fouillen, Sébastien Lyonnais, et al.
International Journal of Radiation Oncology, Biology, Physics|April 28, 2022
Toward Neuro-Oncologic Clinical Trials of High-Dose-Rate Synchrotron Microbeam Radiation Therapy: First Treatment of a Spontaneous Canine Brain TumorJean-François Adam, Jacques Balosso, Sam Bayat, et al.
Science (New York, N.Y.)|August 10, 2013
Response to comment on "The placental mammal ancestor and the post-K-Pg radiation of placentals"Maureen A O'Leary, Jonathan I Bloch, John J Flynn, et al.
Nature Communications|August 16, 2022
Skyrmions in synthetic antiferromagnets and their nucleation via electrical current and ultra-fast laser illuminationRoméo Juge, Naveen Sisodia, Joseba Urrestarazu Larrañaga, et al.
Science (New York, N.Y.)|February 9, 2013
The placental mammal ancestor and the post-K-Pg radiation of placentalsMaureen A O'Leary, Jonathan I Bloch, John J Flynn, et al.
Nature Metabolism|October 1, 2025
DDHD2 provides a flux of saturated fatty acids for neuronal energy and functionSaber H Saber, Nyakuoy Yak, Xuan Ling Hilary Yong, et al.
Arthritis and Rheumatism|May 28, 2010
Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registryBenjamin Terrier, Zahir Amoura, Philippe Ravaud, et al.
The Lancet. Infectious Diseases|June 28, 2015
Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort studyTimothy M Walker, Thomas A Kohl, Shaheed V Omar, et al.
Rheumatology (Oxford, England)|November 3, 2021
New-onset inflammatory bowel diseases among IL-17 inhibitor-treated patients: results from the case-control MISSIL studyJean-Guillaume Letarouilly, Thao Pham, Adeline Pierache, et al.
Pageof 159